The federal agency once opposed to finding any benefit from marijuana now wants more research on the plant.
Nora Volkow, director of the National Institute on Drug Abuse, recently wrote an opinion piece in the Huffington Post detailing her support for further research on cannabis, and especially the therapeutic found within it known as cannabidiol (CBD).
“There is reason to believe (CBD) may have a range of uses in medicine, including in the treatment of seizures and other neurological disorders,” Volkow says. “In the impassioned, often emotional debates these days over medical marijuana, CBD is often cited as one of the main reasons restrictions on marijuana should be loosened.”
While there’s only so much research on CBD to go on, the compound is known to be especially effective against debilitating disorders such as epilepsy and Multiple Sclerosis. More recently, the compound has also been found to increase the recovery rate of bone fractures.
Volkow hopes that further research is conducted quickly so that patients who could seek relief from CBD can access it sooner rather than later.
“Much more research needs to be done, but it should be done quickly,” Volkow says. “Parents can’t wait — their children are growing; their children’s brains are actively developing; and the repeated seizures may be damaging this growth. Parents currently must navigate states’ medical marijuana laws or defy the law to obtain CBD extracts — which, in the current unregulated market, may be of questionable quality and content.”
Read the rest of Volkow’s opinion at the Huffington Post.